Inês Vaz-Luís

4.5k total citations · 1 hit paper
116 papers, 1.9k citations indexed

About

Inês Vaz-Luís is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Inês Vaz-Luís has authored 116 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Oncology, 36 papers in Cancer Research and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Inês Vaz-Luís's work include Cancer survivorship and care (33 papers), Breast Cancer Treatment Studies (33 papers) and Cancer Treatment and Pharmacology (16 papers). Inês Vaz-Luís is often cited by papers focused on Cancer survivorship and care (33 papers), Breast Cancer Treatment Studies (33 papers) and Cancer Treatment and Pharmacology (16 papers). Inês Vaz-Luís collaborates with scholars based in France, United States and Italy. Inês Vaz-Luís's co-authors include Nancy U. Lin, Eric P. Winer, Rachel A. Freedman, Antonio Di Meglio, Nancy L. Keating, William T. Barry, Ann H. Partridge, Rosaria Condorelli, Melissa E. Hughes and Harold J. Burstein and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Inês Vaz-Luís

105 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer

2021 168 citations Maria Alice Franzoi, Lucia Del Mastro et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inês Vaz-Luís France	23	1.3k	723	533	194	191	116	1.9k
Thomas Ruhstaller Switzerland	29	1.7k 1.3×	613 0.8×	949 1.8×	126 0.6×	199 1.0×	85	2.9k
Carlos H. Bárcenas United States	26	1.0k 0.8×	767 1.1×	327 0.6×	255 1.3×	332 1.7×	106	2.1k
Lucìa Mangone Italy	22	1.3k 1.0×	373 0.5×	484 0.9×	158 0.8×	318 1.7×	96	2.1k
Neelima Denduluri United States	23	1.7k 1.3×	821 1.1×	700 1.3×	203 1.0×	200 1.0×	67	2.8k
Nicholas Wilcken Australia	26	1.5k 1.2×	647 0.9×	702 1.3×	227 1.2×	218 1.1×	65	2.4k
Vani Parmar India	20	847 0.7×	782 1.1×	342 0.6×	159 0.8×	239 1.3×	106	1.5k
Hongchao Pan United Kingdom	9	710 0.5×	654 0.9×	442 0.8×	270 1.4×	127 0.7×	19	1.7k
Susan Dent Canada	27	1.1k 0.8×	495 0.7×	313 0.6×	271 1.4×	141 0.7×	81	2.1k
Vernon Harvey New Zealand	22	1.3k 1.0×	489 0.7×	357 0.7×	163 0.8×	84 0.4×	44	1.8k
Halle C. F. Moore United States	22	1.0k 0.8×	387 0.5×	415 0.8×	127 0.7×	210 1.1×	88	1.6k

Countries citing papers authored by Inês Vaz-Luís

Since Specialization

Citations

This map shows the geographic impact of Inês Vaz-Luís's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inês Vaz-Luís with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inês Vaz-Luís more than expected).

Fields of papers citing papers by Inês Vaz-Luís

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inês Vaz-Luís. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inês Vaz-Luís. The network helps show where Inês Vaz-Luís may publish in the future.

Co-authorship network of co-authors of Inês Vaz-Luís

This figure shows the co-authorship network connecting the top 25 collaborators of Inês Vaz-Luís. A scholar is included among the top collaborators of Inês Vaz-Luís based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inês Vaz-Luís. Inês Vaz-Luís is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Reilly, Séamus, Inês Vaz-Luís, Virginie Adam, et al.. (2025). Advancing equitable access to innovation in breast cancer. npj Breast Cancer. 11(1). 71–71. 1 indexed citations

Kastora, Stavroula, Eirini Pantiora, Hatem A. Azim, et al.. (2025). Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussion. Cancer Treatment Reviews. 133. 102880–102880. 3 indexed citations

Vaz-Luís, Inês, Graziella Mazza, Angela DeMichele, et al.. (2025). 485MO Health-related quality of life (HRQoL) from the PATINA trial (AFT-38): Impact of adding palbociclib to HER2 and endocrine therapy (ET) after induction in HR+/HER2+ metastatic breast cancer (MBC). Annals of Oncology. 36. S378–S378. 1 indexed citations

Franzoi, Maria Alice, Antonio Di Meglio, Stefan Michiels, et al.. (2024). Patient-Reported Quality of Life 6 Years After Breast Cancer. JAMA Network Open. 7(2). e240688–e240688. 2 indexed citations

Meglio, Antonio Di, Julie Havas, Martina Pagliuca, et al.. (2024). Patterns of depressive symptoms among survivors of early-stage breast cancer (BC).. Journal of Clinical Oncology. 42(16_suppl). 12009–12009.

Franzoi, Maria Alice, Arlindo R. Ferreira, Thomas Grellety, et al.. (2024). Abstract PO1-10-10: Leveraging technology to optimize symptom management and patient empowerment in routine breast cancer care: implementation of a remote patient monitoring (RPM) pathway across 24 hospitals in Europe. Cancer Research. 84(9_Supplement). PO1–10.

Sandoval, José Luís, Maria Alice Franzoi, Antonio Di Meglio, et al.. (2024). Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort. Journal of Clinical Oncology. 42(24). 2908–2917. 7 indexed citations

Franzoi, Maria Alice, Arlindo R. Ferreira, Antoine Lemaire, et al.. (2024). Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium. The Lancet Regional Health - Europe. 44. 101005–101005. 15 indexed citations

Epstein, Jonathan, Élise Martin, Antonio Di Meglio, et al.. (2024). An effort to improve the collection of patient-generated data: readability and understandability of patient-reported outcomes measures in a survivorship cohort. Quality of Life Research. 33(5). 1267–1274. 1 indexed citations

10.

Franzoi, Maria Alice, Arnaud Pagès, Antonio Di Meglio, et al.. (2024). Evaluating the Implementation of Integrated Proactive Supportive Care Pathways in Oncology: Master Protocol for a Cohort Study. JMIR Research Protocols. 13. e52841–e52841. 2 indexed citations

11.

Licaj, Idlir, Elodie Coquan, Tienhan Sandrine Dabakuyo‐Yonli, et al.. (2023). Baseline quality of life and chemotherapy toxicities in patients with early breast cancer. Cancer. 129(7). 1085–1095. 4 indexed citations

12.

Deluche, Élise, Stefan Michiels, Christophe Perrin, et al.. (2023). LESS: Single-arm study to de-escalate adjuvant endocrine therapy duration in post-menopausal women with HR+ HER2- early-stage breast cancer at very low risk of metastasis.. Journal of Clinical Oncology. 41(16_suppl). TPS615–TPS615. 3 indexed citations

13.

Soldato, Davide, Julie Havas, Tracy E. Crane, et al.. (2022). Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer. Cancer. 128(19). 3552–3563. 3 indexed citations

14.

Martin, Élise, Antonio Di Meglio, Cécile Charles, et al.. (2021). Use of mHealth to Increase Physical Activity Among Breast Cancer Survivors With Fatigue: Qualitative Exploration. JMIR Cancer. 7(1). e23927–e23927. 14 indexed citations

15.

Gbenou, Arnauld, Julie Havas, Élise Martin, et al.. (2021). Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer. The Breast. 57. 43–48. 3 indexed citations

16.

Leone, José Pablo, Bernard F. Cole, Meredith M. Regan, et al.. (2020). Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial. Cancer. 127(5). 700–708. 5 indexed citations

17.

Lambertini, Matteo, Christine Campbell, Richard D. Gelber, et al.. (2019). Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial. Breast Cancer Research and Treatment. 177(1). 103–114. 26 indexed citations

18.

Freedman, Rachel A., Nancy L. Keating, Nancy U. Lin, et al.. (2018). Breast cancer‐specific survival by age: Worse outcomes for the oldest patients. Cancer. 124(10). 2184–2191. 55 indexed citations

19.

Meglio, Antonio Di, Rachel A. Freedman, Nancy U. Lin, et al.. (2016). Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis. Breast Cancer Research and Treatment. 157(3). 587–596. 31 indexed citations

20.

Vaz-Luís, Inês, Melissa E. Hughes, Angel M. Cronin, et al.. (2015). Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi‐institutional study. Cancer. 121(12). 1937–1948. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact